Federal Hemp Regulation Bill Gains New Bipartisan Support, Now Has Eight Sponsors

Key Points
  • The Hemp Enforcement, Modernization, and Protection Act (House Resolution 7212) aims to create a national regulatory framework for cannabinoid hemp products and has gained bipartisan support in the U.S. House with eight sponsors.
  • The bill is sponsored by Rep. Morgan Griffith (R-VA) and cosponsored by four Democrats and four Republicans, including recent additions Rep. Adelita Grijalva (D-AZ) and Rep. John James (R-MI).
  • The legislation proposes amending the Federal Food, Drug, and Cosmetic Act to establish federal standards for labeling, testing, manufacturing, product listings, facility registration, and recalls of cannabinoid hemp products.
  • The bill would enforce federal oversight similar to other consumer products, require accurate labeling and safety testing, prohibit sales to under-21 individuals, and has been referred to the House Energy and Commerce Committee.

A federal bill that would create a national regulatory framework for cannabinoid hemp products has gained new support in the U.S. House.

The Hemp Enforcement, Modernization, and Protection Act, filed as House Resolution 7212, now has eight total sponsors, including the primary sponsor and seven cosponsors. The measure is sponsored by U.S. Representative Morgan Griffith (R-VA), with Representative Marc Veasey (D-TX) joining as an original cosponsor.

The most recent lawmaker to sign on is U.S. Representative Adelita Grijalva (D-AZ), who became a cosponsor on June 2. This follows Rep. John James (R-MI), who joined as a sponsor in Mid-May. Other cosponsors include Representatives Dan Crenshaw (R-TX), John James (R-MI), Sylvia Garcia (D-TX), James Baird (R-IN) and Eugene Vindman (D-VA).

The current sponsor list includes four Democrats and four Republicans, giving the proposal bipartisan backing.

The bill would amend the Federal Food, Drug, and Cosmetic Act to establish federal standards for cannabinoid hemp products. This would include requirements related to labeling, testing, manufacturing, product listings, facility registration and recalls.

Under the proposal, companies producing cannabinoid hemp products would be subject to federal oversight similar to other regulated consumer products, with rules meant to ensure products are accurately labeled, tested for safety and traceable if problems arise. The measure would also give federal regulators clearer authority to address noncompliant products and require recalls when necessary.

The proposal would also prohibit the sale of cannabinoid hemp products to anyone under 21.

The bill has been referred to the House Energy and Commerce Committee.